Clinical trial
Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
NCT00496171 · Photocure, Industry · Terminated
Key facts
| NCT number | NCT00496171 |
|---|---|
| Title | Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers |
| Official title | A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers |
| Lead sponsor | Photocure, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Healthy |
| First posted | Jul 4, 2007 |
| Last update posted | Jan 16, 2009 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: